cancer-therapy-and-biomarkers-2016_tracks-abstracts

34 / 36

Volume 2, Issue 3(Suppl) Oncol Cancer Case Rep
ISSN: 2471-8556 an open access journal
Page 65
Notes:
Cancer Therapy & Biomarkers 2016
December 05-07, 2016
conferenceseries.com
CANCER THERAPY,
BIOMARKERS & CLINICAL RESEARCH
15th World Congress on
December 05-07, 2016 Philadelphia, USA
Biomarker concentration acting as the indicators for chemicals health risk assessment: The case
study in Thailand
Nalinee Sripaung
Bureau of Occupational and Environmental Diseases-Ministry of Public Health, Thailand
According to the usage of type of metabolites in blood and urine acting as the biomarker and the concentration of bio-
marker acting as the indicator for health risk assessment. The health risk management concerning with chemicals toxicity
faces to the problem of how to use the concentration of biomarker to be the suitable indicator for health risk assessment. Pres-
ently, there is no any safety value adjustment of health risk assessment for people’s health in community. Therefore, in the field
of prevention and control of occupational and environmental diseases has to use the safety value of biomarker concentration
for worker’s health to be the safety value for people’s health indicator in community for health risk assessment resulted from
chemicals pollution. The study of using the safety value of worker’ health to identify people’s health in community in case of
health surveillance of chemicals incidents was proceeded during the year 2015-2016. It was found that biomarkers concen-
trations of VOCs (Volatile Organic Solvents) of worker’s health were higher than the actual baseline chemicals exposure of
People’s health in community. The result from the adjustment the risk group of people in community by worker’ s health safety
value indicated the lower amount of people than the actual amount risk group. Thus, the baseline concentration of biomarker
should be further studied to be the health surveillance value for people’ health risk assessment caused by chemicals toxicity.
Biography
Nalinee Sripaung has completed her PhD from Tokyo Medical and Dental University, Japan. She is the Assistant Director of Bureau of Occupational and
Environmental Diseases, Department of Disease Control, Ministry of Public Health, Thailand. She has experience working with the Thai National Chemicals
Management Strategy for prevention and control of occupational and environmental diseases. She has published more than 30 papers in chemicals dissemination
and reputed journals and has been serving as an Editorial Board Member of reputed journal in Thailand.
Nalinee Sripaung, Oncol Cancer Case Rep 2016,2:3(Suppl)